Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dilek Çuhadar Erçelebi"'
Autor:
Hale Ates, Kurtuluş Aksu, Dilek Çuhadar Erçelebi, Süleyman Türkyılmaz, Buket Basa Akdogan, Özlem Özdedeoğlu, Gözde Köycü Buhari, İlkay Koca Kalkan
Publikováno v:
Ankara Medical Journal, Vol 22, Iss 3, Pp 404-414 (2022)
INTRODUCTION: There are conflicting results regarding the sensitivity of skin tests and cross-reactions between quinolones in quinolone allergy. In our study, we aimed to evaluate the results of skin tests and provocation tests performed with quinolo
Externí odkaz:
https://doaj.org/article/331c285cc60f402294ebdfccebc0a47e
Autor:
Gürgün Tuğçe Vural Solak, Kurtuluş Aksu, Musa Topel, Dilek Çuhadar Erçelebi, Selma Yeşilkaya, Şenay Demir, Gözde Köycü Buhari, İlkay Koca Kalkan, Hale Ateş, Sakine Nazik Bahçecioğlu
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 28(6)
Introduction Osimertinib is an approved therapy for patients with a Thr790met (T790M) mutation diagnosed with non-small cell lung cancer (NSCLC) that progresses during epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy. How
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0906311ab2477d821a6e37f7789af08e
https://pubmed.ncbi.nlm.nih.gov/35060790
https://pubmed.ncbi.nlm.nih.gov/35060790
Autor:
Kurtuluş, Aksu, Dilek, Çuhadar Erçelebi, Şeref, Özkara, Süleyman, Türkyılmaz, İlkay, Koca Kalkan, Özlem, Dedeoğlu, Buket, Başa Akdoğan, Hale, Ateş, Gözde, Köycü Buhari
Publikováno v:
Tuberkuloz ve toraks. 69(3)
Antibiotic hypersensitivity reactions can lead to marked morbidity, mortality and inadequate treatment options. Mycobacterium abscessus infection is a difficult management system for clinicians since it most commonly involves the lungs, progresses if
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::00f92f8e29b9e8cf247b39b3c4d5106d
https://pubmed.ncbi.nlm.nih.gov/34581162
https://pubmed.ncbi.nlm.nih.gov/34581162
Autor:
Ilkay Koca Kalkan, Hale Ates, Kurtulus Aksu, Selma Yesilkaya, Musa Topel, Dilek Cuhadar Ercelebi, Suleyman Turkyilmaz, Ali Oncul, Senay Demir
Publikováno v:
World Allergy Organization Journal, Vol 14, Iss 7, Pp 100558- (2021)
Background: Allergen immunotherapy (AIT) must be continued for 3 years, to achieve a long-term modifying effect. Adherence is a key to ensure effectiveness. The objective of this study was, first of all, to evaluate the adherence with subcutaneous im
Externí odkaz:
https://doaj.org/article/e30e714e36cd4c038b301db0b9119e20